Events FDA Fraud 
Healthcare IT Today
DECEMBER 30, 2024
This shift, driven by the FDA’s Diversity Action Plans, will accelerate trial enrollment, improve representation, and ultimately enhance patient safety by ensuring more diverse data in research. Beyond 2025, developments will include blockchain integration, advanced fraud detection, and more sophisticated predictive analytics.
MedTrainer
JANUARY 12, 2024
Department of Health and Human Services focuses on preventing fraud, abuse, and waste in federal healthcare programs. Food and Drug Administration (FDA): The FDA regulates compliance in pharmaceuticals, medical devices, and biotechnology products. Office of Inspector General (OIG): This independent agency within the U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
NY Health Law
JANUARY 3, 2025
Since approving Gilenya in 2010, the FDA has imposed a first-dose observation requirement for new patients, who must be monitored by a doctor while attached to an electrocardiogram machine for six hours. Novartis Pharmaceuticals Corp.
AIHC
JUNE 6, 2023
Compromised personal data can have serious consequences, including identity theft, financial fraud, and job losses in addition to OCR HIPAA fines and costs associated with breach notifications. The best thing you can do is have reliable cybersecurity protection, and ensure you will find out ASAP in the event of being affected.
AIHC
JUNE 6, 2023
Compromised personal data can have serious consequences, including identity theft, financial fraud, and job losses in addition to OCR HIPAA fines and costs associated with breach notifications. The best thing you can do is have reliable cybersecurity protection, and ensure you will find out ASAP in the event of being affected.
Health Law Advisor
MARCH 7, 2023
Should the final rules limit the issuance of prescriptions of controlled medications to the FDA-approved indications contained in the FDA-approved labeling for those medications? DEA has specifically requested feedback on whether it should limit telemedicine prescribing to only the drug’s FDA-approved indications. 1301.28.
Health Populi
SEPTEMBER 8, 2021
Artificial intelligence and health equity were two key themes discussed during #HIMSS21, and Dr. Halamka’s concerns echoed through the week-long event. The Pew Trusts recently discussed prospects for the FDA to regulate AI in health care.
Expert insights. Personalized for you.
88 
Let's personalize your content